Aker (AKER:NASDAQ) Investor Relations Material

Overview

Akers Biosciences is currently working towards the development and production of a COVID-19 vaccine, in partnership with Premas Biotech. The company's board is also exploring strategic options to increase shareholder value.

Annual Reports

Frequently Asked Questions

What is Aker's ticker?

Aker's ticker is AKER

What exchange is Aker traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Aker's headquarters?

They are based in West Deptford, New Jersey

How many employees does Aker have?

There are 11-50 employees working at Aker

What is Aker's website?

It is akerasa.com/en/about

What type of sector is Aker?

Aker is in the Healthcare sector

What type of industry is Aker?

Aker is in the Medical Instruments & Supplies industry

Who are Aker's peers and competitors?

The following five companies are Aker's industry peers:

- Hill-Rom Holdings, Inc.

- AngioDynamics

- Integra LifeSciences

- IsoRay, Inc.

- Merit Medical Systems